Regional Expansion Oncquest’s expansion in Delhi and new Maharashtra partnerships create target-rich opportunities to win hospital networks and clinics in these regions with end-to-end diagnostic services.

Full Test Menu With over 4,000 tests across routine, specialized, and genomic panels, Oncquest offers a single partner for hospitals seeking breadth, enabling easier cross-selling of core and advanced diagnostics.

Genomic Leadership Strong molecular diagnostics and cancer testing capabilities including second opinions position Oncquest to upsell to oncology centers and research institutions needing advanced genomics.

Pan-Asia Logistics A national footprint of 50 labs, 500 collection centres, and 2,500 service associates supports scalable sampling, processing, and fast turnaround for multi-site healthcare networks.

Credible Growth Revenue in the USD 25–50 million range, backed by Dabur founders and pandemic resilience, provides credible, enterprise-level partnership potential for large hospital groups and diagnostics chains.